Decisions on marketing authorisations will be sent electronically to Danish recipients from October 2017

From 1 October 2017, the Danish Medicines Agency’s licensing division will send decisions on marketing authorisations to Danish recipients and companies by digital post. This includes all letters about new marketing authorisations, variations and renewals as well as any annexes.

All digital post will be encrypted which means that the level of security is very high – even higher than for ordinary mail or emails.

Letters about decisions to companies outside Denmark will still be sent by ordinary mail.